11572 | Humans |
7992 | Lymphedema |
6625 | Female |
4496 | Male |
4165 | Middle Aged |
4103 | Adult |
2787 | Aged |
2542 | Animals |
2283 | Elephantiasis, Filarial |
1872 | Breast Neoplasms |
1559 | Adolescent |
1301 | Leg |
1178 | Child |
1055 | Wuchereria bancrofti |
1005 | Arm |
942 | Lymphatic System |
940 | Lymph Node Excision |
913 | Postoperative Complications |
869 | Aged, 80 and over |
853 | Elephantiasis |
852 | Treatment Outcome |
820 | Mastectomy |
752 | Lymphography |
699 | Lymph Nodes |
682 | Child, Preschool |
666 | Follow-Up Studies |
616 | Diagnosis, Differential |
569 | Edema |
555 | Chronic Disease |
542 | Lymphatic Metastasis |
514 | Filariasis |
507 | Retrospective Studies |
506 | Time Factors |
496 | Lymphatic Vessels |
489 | Risk Factors |
489 | Infant |
484 | Young Adult |
454 | Quality of Life |
454 | Axilla |
436 | Prevalence |
428 | Antigens, Helminth |
408 | Skin Neoplasms |
406 | Filaricides |
403 | Diethylcarbamazine |
401 | Syndrome |
394 | Microfilariae |
365 | Combined Modality Therapy |
352 | Lower Extremity |
349 | Brugia |
343 | Physical Therapy Modalities |
342 | Prospective Studies |
336 | Prognosis |
334 | India |
330 | Surveys and Questionnaires |
328 | Skin |
322 | Neoplasm Staging |
319 | Drainage |
308 | Bandages |
307 | Neoplasms |
301 | Mice |
285 | Microsurgery |
281 | Sentinel Lymph Node Biopsy |
279 | Infant, Newborn |
265 | Radionuclide Imaging |
264 | Veins |
251 | Lymphatic Diseases |
251 | Antibodies, Helminth |
250 | Scrotum |
241 | Brugia malayi |
236 | Insect Vectors |
236 | Extremities |
235 | Lymphangiosarcoma |
233 | Lymphoscintigraphy |
225 | Lymph |
219 | Venous Insufficiency |
217 | Cross-Sectional Studies |
216 | Hemangiosarcoma |
210 | Severity of Illness Index |
210 | Anastomosis, Surgical |
208 | Disease Models, Animal |
206 | Magnetic Resonance Imaging |
201 | Neoplasm Recurrence, Local |
200 | Methods |
199 | Radiotherapy |
199 | Incidence |
197 | Upper Extremity |
197 | Endemic Diseases |
196 | Surgical Flaps |
195 | Ivermectin |
191 | Lymphangiogenesis |
189 | Pressure |
188 | Tomography, X-Ray Computed |
187 | Enzyme-Linked Immunosorbent Assay |
182 | Exercise Therapy |
179 | Dogs |
178 | Sensitivity and Specificity |
178 | Immunoglobulin G |
178 | Age Factors |
174 | Survivors |
174 | Genital Diseases, Male |
174 | Biopsy |
170 | Recurrence |
169 | Albendazole |
168 | Massage |
157 | Skin Transplantation |
155 | Varicose Veins |
155 | Culex |
155 | Carcinoma, Squamous Cell |
154 | Thrombophlebitis |
154 | Melanoma |
154 | Lymphangitis |
153 | Ultrasonography |
152 | Radiotherapy, Adjuvant |
151 | Radiography |
150 | Skin Diseases |
150 | Reproducibility of Results |
149 | Rats |
144 | Uterine Cervical Neoplasms |
141 | Pleural Effusion |
139 | Patient Education as Topic |
137 | Anthelmintics |
136 | Obesity |
134 | Vascular Diseases |
134 | Disease |
134 | Case-Control Studies |
132 | Drug Therapy, Combination |
131 | Pregnancy |
130 | Pedigree |
129 | Cellulitis |
127 | Penile Diseases |
126 | Phlebography |
125 | Erysipelas |
120 | Nail Diseases |
119 | Onchocerciasis |
118 | Wound Healing |
118 | Anti-Bacterial Agents |
117 | Stockings, Compression |
117 | Phenotype |
117 | Cohort Studies |
116 | Penis |
116 | Pain |
114 | Testicular Hydrocele |
112 | Vascular Endothelial Growth Factor Receptor-3 |
112 | Risk Assessment |
112 | Reconstructive Surgical Procedures |
112 | Mutation |
112 | Leg Ulcer |
110 | Vulvar Neoplasms |
110 | Mastectomy, Segmental |
108 | Transplantation, Autologous |
108 | Postoperative Care |
108 | Pilot Projects |
106 | Lymphangioma |
105 | Predictive Value of Tests |
103 | Mastectomy, Radical |
103 | Immunohistochemistry |
101 | Compression Bandages |
100 | Sex Factors |
100 | Self Care |
100 | Lymphangiectasis |
100 | Abnormalities, Multiple |
99 | Health Knowledge, Attitudes, Practice |
98 | Vascular Endothelial Growth Factor C |
98 | Survival Rate |
98 | Groin |
96 | Mosquito Control |
96 | Gerbillinae |
95 | Drug Administration Schedule |
94 | Larva |
93 | Radiation Injuries |
93 | Ethiopia |
91 | Neoplasm Metastasis |
91 | Culicidae |
91 | Contrast Media |
91 | Adenocarcinoma |
90 | Range of Motion, Articular |
90 | Molecular Sequence Data |
90 | Hand |
90 | Chyle |
90 | Age Distribution |
89 | Lipectomy |
89 | Genital Neoplasms, Female |
89 | Endothelial Cells |
87 | Hysterectomy |
87 | Adipose Tissue |
86 | Soft Tissue Neoplasms |
86 | Rural Population |
85 | Randomized Controlled Trials as Topic |
85 | Inflammation |
85 | Global Health |
85 | Carcinoma |
85 | Breast |
85 | Acute Disease |
84 | Inguinal Canal |
83 | Double-Blind Method |
83 | Chylothorax |
82 | Lymphangiectasis, Intestinal |
82 | Coumarins |
81 | Sarcoma, Kaposi |
81 | Palliative Care |
81 | Longitudinal Studies |
81 | Hindlimb |
80 | Patient Compliance |
79 | Turner Syndrome |
79 | Skin Care |
79 | Malaria |
79 | Body Mass Index |
79 | Antineoplastic Combined Chemotherapy Protocols |
78 | Pigmentation Disorders |
78 | Obesity, Morbid |
78 | Exercise |
78 | Anopheles |
77 | Wuchereria |
77 | Polymerase Chain Reaction |
77 | Forkhead Transcription Factors |
77 | Cells, Cultured |
76 | Electric Impedance |
76 | Disease Progression |
75 | Indocyanine Green |
75 | Chemotherapy, Adjuvant |
75 | Anthropometry |
74 | United Kingdom |
74 | Radiopharmaceuticals |
74 | Coloring Agents |
74 | Activities of Daily Living |
72 | Vascular Surgical Procedures |
72 | Leg Dermatoses |
72 | Feasibility Studies |
72 | Cytokines |
72 | Antineoplastic Agents |
72 | Adaptation, Psychological |
71 | United States |
71 | Survival Analysis |
71 | Socioeconomic Factors |
71 | Rural Health |
71 | Models, Biological |
71 | Fatal Outcome |
71 | Brazil |
70 | Varicose Ulcer |
70 | Amputation |
69 | Recombinant Proteins |
69 | Population Surveillance |
69 | Mice, Inbred C57BL |
69 | Fibrosis |
69 | Eyelashes |
68 | Technetium |
68 | Head and Neck Neoplasms |
68 | China |
67 | Thigh |
67 | Surgical Wound Infection |
67 | Rabbits |
66 | Radiotherapy Dosage |
66 | Nursing Assessment |
66 | Lymphoma |
66 | Disease-Free Survival |
66 | Analysis of Variance |
66 | Amino Acid Sequence |
65 | Neglected Diseases |
65 | Lymphocyte Activation |
65 | Carcinoma, Ductal, Breast |
64 | Tanzania |
64 | Signal Transduction |
64 | Saphenous Vein |
64 | Clothing |
64 | Antibodies, Monoclonal |
62 | Mammaplasty |
62 | Equipment Design |
62 | Endometrial Neoplasms |
61 | Soil |
61 | Pelvis |
61 | Mice, Inbred BALB C |
61 | Logistic Models |
61 | Haiti |
60 | Schistosomiasis |
60 | Medical Records |
59 | Morbidity |
59 | Microscopy, Electron |
59 | Lymphadenitis |
59 | Carrier State |
59 | Base Sequence |
59 | Aedes |
58 | Preoperative Care |
58 | Practice Guidelines as Topic |
58 | Foot |
57 | Tropical Medicine |
57 | Angiography |
56 | World Health Organization |
56 | Surgical Procedures, Operative |
56 | Sex Distribution |
56 | Genetic Predisposition to Disease |
56 | Foot Diseases |
56 | Attitude to Health |
55 | Filarioidea |
54 | Program Evaluation |
54 | Patient Care Team |
54 | Forearm |
54 | Diuretics |
54 | Disease Eradication |
54 | Comorbidity |
53 | Proteins |
53 | Penile Neoplasms |
53 | Neoplasm Invasiveness |
53 | Mastectomy, Modified Radical |
53 | Helminth Proteins |
52 | Thoracic Duct |
52 | Regional Blood Flow |
52 | Myxedema |
52 | Multivariate Analysis |
52 | Macrophages |
52 | Face |
51 | Vulva |
51 | Prostatic Neoplasms |
51 | Phlebitis |
51 | Helminthiasis |
51 | Evidence-Based Medicine |
51 | Developing Countries |
51 | Chylous Ascites |
50 | Vulvar Diseases |
50 | Venous Thrombosis |
50 | Technetium Tc 99m Aggregated Albumin |
50 | Neck |
50 | Clinical Trials as Topic |
50 | Biomarkers |
49 | Thrombosis |
49 | T-Lymphocytes |
49 | Shoulder |
49 | Leg Injuries |
49 | Fatigue |
49 | Capillary Permeability |
48 | Social Support |
48 | Hyperplasia |
48 | Cell Proliferation |
48 | Capillaries |
48 | Arthritis, Rheumatoid |
47 | Wolbachia |
47 | Necrosis |
47 | Immunity, Cellular |
47 | Health Surveys |
47 | Africa |
46 | Surgery, Plastic |
46 | Regression Analysis |
46 | Regeneration |
46 | Papua New Guinea |
46 | Omentum |
46 | Hodgkin Disease |
46 | History, 20th Century |
45 | Tumor Suppressor Proteins |
45 | Technetium Tc 99m Sulfur Colloid |
45 | Parasitemia |
45 | Nigeria |
45 | Neoplasms, Radiation-Induced |
45 | Intermittent Pneumatic Compression Devices |
45 | Genotype |
45 | Endothelium, Lymphatic |
45 | Cats |
44 | Protein-Losing Enteropathies |
44 | Neoplasms, Second Primary |
44 | Lymphocytes |
44 | Immunoglobulin E |
44 | Femoral Vein |
44 | DNA, Helminth |
44 | Biopsy, Needle |
44 | Algorithms |
43 | Sarcoma |
43 | Reoperation |
43 | Postoperative Period |
43 | Liver |
43 | Indonesia |
43 | Ghana |
42 | Transcription Factors |
42 | Physical Examination |
42 | Granuloma |
42 | Genitalia |
42 | Dose-Response Relationship, Drug |
42 | Depression |
42 | Communicable Disease Control |
42 | Body Image |
41 | Public Health |
41 | Posture |
41 | Pain Measurement |
41 | Noonan Syndrome |
41 | Microcirculation |
41 | Mice, Knockout |
41 | Cost of Illness |
41 | Blood Vessels |
40 | Toes |
40 | Patient Satisfaction |
40 | Neurofibromatosis 1 |
40 | Nails |
40 | Lymphocele |
40 | Hemangioma |
40 | Heart Failure |
40 | Extracellular Space |
40 | Diagnostic Imaging |
40 | Cicatrix |
40 | Abdomen |
39 | Uterine Neoplasms |
39 | Risk |
39 | Reference Values |
39 | Qualitative Research |
39 | Plethysmography |
39 | Microcephaly |
39 | Health Status |
39 | Eyelid Diseases |
39 | Evaluation Studies as Topic |
39 | Disease Vectors |
39 | Antiparasitic Agents |
38 | Length of Stay |
38 | Egypt |
38 | Blood Pressure |
37 | Yellow Nail Syndrome |
37 | Wounds and Injuries |
37 | Streptococcal Infections |
37 | Shoulder Joint |
37 | Recovery of Function |
37 | Organ Size |
37 | Neovascularization, Pathologic |
37 | Mice, Transgenic |
37 | Karyotyping |
37 | Iliac Vein |
37 | Blotting, Western |
37 | Blood Proteins |
37 | Arterial Occlusive Diseases |
37 | Administration, Oral |
36 | Vascular Endothelial Growth Factor A |
36 | Lung Neoplasms |
36 | Ligation |
36 | Interferon-gamma |
36 | Intellectual Disability |
36 | Genitalia, Male |
36 | Fluorescent Antibody Technique |
36 | Fistula |
36 | Disease Management |
36 | Cost-Benefit Analysis |
36 | Connective Tissue |
36 | Cloning, Molecular |
36 | Breast Diseases |
36 | Anticoagulants |
35 | Venous Pressure |
35 | Suture Techniques |
35 | Stress, Psychological |
35 | Sri Lanka |
35 | Research |
35 | Pelvic Neoplasms |
35 | Klippel-Trenaunay-Weber Syndrome |
35 | Insecticides |
35 | Immunosuppressive Agents |
35 | Homeodomain Proteins |
35 | Drug Combinations |
35 | DNA Mutational Analysis |
35 | Burns |
35 | Anti-Inflammatory Agents |
34 | Patient Selection |
34 | Pain, Postoperative |
34 | Pain Management |
34 | Neoplasms, Multiple Primary |
34 | Kenya |
34 | Gene Expression Regulation |
34 | Collagen |
34 | Breast Cancer Lymphedema |
33 | Lung Diseases |
33 | Ischemia |
33 | Host-Parasite Interactions |
33 | Genes, Dominant |
33 | DNA-Binding Proteins |
33 | Anxiety |
32 | Thailand |
32 | Statistics, Nonparametric |
32 | Skin Ulcer |
32 | Referral and Consultation |
32 | Neovascularization, Physiologic |
32 | Interviews as Topic |
32 | Health Education |
32 | Epitopes |
32 | Doxycycline |
32 | Cell Movement |
32 | Body Composition |
31 | Polynesia |
31 | Lung |
31 | Laparoscopy |
31 | International Cooperation |
31 | History, 19th Century |
31 | Health Services Needs and Demand |
31 | Focus Groups |
31 | Fluorescent Dyes |
31 | Fever |
31 | Crohn Disease |
31 | Blood |
31 | Australia |
31 | Acquired Immunodeficiency Syndrome |
30 | Urine |
30 | Urban Population |
30 | Tropical Climate |
30 | Preventive Health Services |
30 | Ovarian Neoplasms |
30 | Kidney Transplantation |
30 | Immunoglobulin M |
30 | Fingers |
30 | Eosinophilia |
30 | Electrophoresis, Polyacrylamide Gel |